Journal of Medicinal Chemistry · 2009 · 81 citations · 23 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryStructure-activity RelationshipsAntibacterial AgentsAntibacterial PharmacologyEnzyme InhibitionStructure-activity Relationship AnalysisAntibacterial Drug DevelopmentAntibiotic DiscoveryAntimicrobial Drug DevelopmentAntimycobacterial Agent SelectionCarbonic Anhydrase InhibitorsNovel Antibacterial AgentsNovel Antibacterial Drug DiscoveryTuberculosis Drug Development
A series of 2-(hydrazinocarbonyl)-3-aryl-1H-indole-5-sulfonamides has been derivatized by reaction with 2,4,6-trimethylpyrylium perchlorate, leading to pyridinium derivatives. The new sulfonamides were evaluated as inhibitors of two beta-carbonic anhydrases (CAs, EC 4.2.1.1) from Mycobacterium tuberculosis, Rv1284 and Rv3273. The whole series showed excellent nanomolar inhibitory activity, with several subnanomolar inhibitors being detected. Rv1284 and Rv3273 have potential for developing antimycobacterial agents with an alternate mechanism of action.
23
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
Stewart T. Cole, Roland Brosch, Julian Parkhill et al. · Nature · 1998 · 7.9K citations · Full text
Claudiu T. Supuran, Andrea Scozzafava, Angela Casini · Medicinal Research Reviews · 2002 · 1.4K citations
Medicine, Biochemistry, Pharmacology +12